Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool November 8, 2010 Rex Moore	Which Stock Will Anchor Our Port? For the Motley Fool Rising Stars portfolio, let's look for a solid and stable dividend payer that could be the anchor of our portfolio for years to come.
The Motley Fool April 12, 2011 Rex Moore	Best Stocks for the Long Haul You need some corporate El Dorado stocks in your portfolio. Here's where to start searching for them.
The Motley Fool December 12, 2011 Rex Moore	December's Best Stocks for the Long Haul Dividend-paying stocks act as "bear-market protectors" and "return accelerators." Here's where to find them.
The Motley Fool May 27, 2011 Rex Moore	Rising Star Buys: More Tech and Health Care Making the halves whole with II-VI, J&J, and Abbott.
The Motley Fool January 10, 2012 Rex Moore	January's Best Stocks for the Long Haul You need some corporate El Dorados in your portfolio. Here's where to find them.
The Motley Fool January 28, 2011 Anand Chokkavelu	10 Core Stocks: A Johnson & Johnson Update The steady reliability of J&J stock will comfort the core of your portfolio when the market gets a boo-boo.
The Motley Fool October 30, 2010 Anand Chokkavelu	7 Pharma Stocks Near 52-Week Highs Here are the top seven companies in the pharmaceutical space (by market cap) that are within spitting distance of their 52-week highs: J&J... Novartis... Merck... GlaxoSmithKline... Abbott... AstraZeneca... Novo Nordisk...
The Motley Fool January 18, 2011 Russ Krull	Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold?
The Motley Fool November 17, 2010 Rex Moore	7 Strong Stocks for Our Portfolio The multivitamin portfolio closes in on its first buy.
The Motley Fool July 26, 2005 Rich Smith	J&J: One Pricey Stock This giant of the health-care world reported its second quarter 2005 earnings last week but, by all appearances, failed to impress Wall Street. Johnson & Johnson's become very big, very pricey.
The Motley Fool January 3, 2011 Rex Moore	Highest-Yielding Pharma Stocks (You Might Actually Want to Buy) How to combine high yield with low risk.
The Motley Fool October 28, 2010 Matt Koppenheffer	Blue Chips Are Crazy Cheap Blue chip stocks are where investors should be focusing, and there's good reason why.
The Motley Fool December 31, 2007 Brian Orelli	Best Stock for 2008: Johnson & Johnson Down on its luck for 2007, here's why Johnson & Johnson's stock will rebound in 2008.
The Motley Fool November 7, 2009 Dan Caplinger	These Dividend Stocks Won't Let You Down Don't put your portfolio at risk.
The Motley Fool March 29, 2011 Rex Moore	Rising Stars: Safe High-Yielders Dividends that get cut or suspended entirely can wreak havoc on a stock price -- and thus your portfolio. Take a look at ten high-yield, low-risk dividend stocks.
The Motley Fool November 15, 2011 Dan Caplinger	Has Abbott Labs Become the Perfect Stock? For long-term investors, Abbott's continuing devotion to up its dividend -- its streak now stands at 39 years -- makes a compelling reason to hold onto your shares.
The Motley Fool April 7, 2011 Rex Moore	Get the Right Stocks in Your Portfolio To know where you're going, you have to see where you've been.
The Motley Fool December 23, 2005 Nathan Parmelee	The Investing Strategy That Keeps Giving The best results from dividends require patience, a long-term time horizon, and excellent companies for your investment dollars.
The Motley Fool June 15, 2006 Selena Maranjian	My Dividends Are Bigger Than Yours Your yield may be 2% when mine is a whopping 13%. Here's the secret.
The Motley Fool July 12, 2011 Todd Wenning	What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors.
The Motley Fool September 11, 2010 Anand Chokkavelu	How Much of a Bargain Is Johnson & Johnson Stock Right Now? Let's take a look to see how cheap shares of Johnson & Johnson are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis.
The Motley Fool November 8, 2011 Brian Wilson	2 Health-Care Stocks for Times of Uncertainty Just because Abbott and Johnson & Johnson don't undertake as much risk as other health-care giants doesn't mean that shareholders won't see impressive growth in revenues.
The Motley Fool September 24, 2010 Anand Chokkavelu	10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list
The Motley Fool March 25, 2010 Anand Chokkavelu	Your Next Big Dividend Stock These are some really good candidates: Merck... ConAgra Foods... Johnson & Johnson... Marathon Oil... Sysco... FPL Group... McDonald's...
The Motley Fool June 14, 2010	One Way to Protect Your Portfolio From a Market Downturn Rather than exit stocks completely, maybe now is the time for investors to focus on steady, stable, dividend-paying stocks.
The Motley Fool December 18, 2008 Selena Maranjian	Best Stock for 2009: Johnson & Johnson Johnson & Johnson is a stock that should let you sleep well at night in 2009.
The Motley Fool September 17, 2010 James Early	Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care.
The Motley Fool May 20, 2011 Andrea Kalvesmaki	Johnson & Johnson's Billion-Dollar Move Orthopedics are the name of the game for this company's future earnings.
The Motley Fool March 28, 2008 Selena Maranjian	His Dividends Are Bigger Than Mine Buy into healthy, growing, dividend-paying companies -- and then hang on to them.
The Motley Fool October 12, 2007 Ryan Fuhrmann	Dueling Fools: Johnson & Johnson Bull Rebuttal The bulls say that J&J's stock record speaks for itself, and that the current negative short-term news and flagging stock price have created a compelling risk/reward trade-off for investors.
The Motley Fool July 9, 2009 Todd Wenning	5 Signs of a Strong Dividend Stock When researching strong and sustainable dividend-paying stocks for your portfolio, you'll want to focus on those that meet these five criteria.
The Motley Fool November 22, 2006 Brian Lawler	Dueling Fools: Johnson & Johnson Bear J&J's dividend does provide investors with some degree of income, but a CD does, too -- without a health-care stock's risks.
The Motley Fool February 11, 2011 Rex Moore	Highest-Yielding Health Care Stocks (You Might Actually Want to Buy) How to combine high yield with low risk.
The Motley Fool November 22, 2006 Steven Mallas	Dueling Fools: Johnson & Johnson Bull There are many ways to expose one's portfolio to the health-care industry. But J&J offers the best upside potential at relatively little risk.
The Motley Fool March 24, 2011 Anand Chokkavelu	Rising Star Buy: Johnson & Johnson It's time to buy shares of Johnson & Johnson, the "health-care mutual fund."
The Motley Fool July 17, 2008 Brian Orelli	Investors Yawn at Abbott Labs' Growth Abbott Labs may be firing on all cylinders, but investors were less than impressed with its earnings release
The Motley Fool January 22, 2009 Todd Wenning	10 Dividend Stocks for the Next Decade and Beyond Following the worst stock market year since the Great Depression, it's natural for investors to seek more stable and less stressful stock strategies. Dividend-paying stocks provide you with an opportunity to achieve both.
The Motley Fool August 28, 2010 Todd Wenning	Dividend Report Card: Johnson & Johnson Does this health-care titan's dividend pass the test?
The Motley Fool November 22, 2006 Steven Mallas	Dueling Fools: Johnson & Johnson Bull Rebuttal Plenty of opportunities lie ahead for Johnson & Johnson, and even in down times, you've got a good defensive stock.
The Motley Fool February 24, 2009 Brian Orelli	Pfizer: Diversified Dreams, Dubious Decisions Pfizer's CEO Jeffrey Kindler said he wants to make his company more like Johnson & Johnson and Abbott Labs, which aren't dependent on one product for success.
The Motley Fool March 8, 2010 Jim Royal	5 Stocks for the Good Life The lowest-risk, most secure way to a great retirement may be to invest in blue-chip stocks.
The Motley Fool June 22, 2011 Rex Moore	High Yielders Unlikely to Blow Up Looking for the biggest dividend payers that won't blow up.
The Motley Fool November 29, 2011 John Grgurich	3 Strong Yields From the Market's Biggest and Brightest Companies Earn sustainable dividends from companies you can count on to stick around: Intel... Microsoft... Johnson & Johnson...
The Motley Fool August 24, 2010 Matt Koppenheffer	How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale?
The Motley Fool October 12, 2007 Billy Fisher	Dueling Fools: Johnson & Johnson Bear The bearish opinion on J&J is that it is an impressive company that may have its best days behind it.
The Motley Fool May 11, 2009 Selena Maranjian	How I'm Grabbing 20% Dividend Yields While the current yield on a stock might be only 2 or 3%, for those who bought it long ago at a lower price, and who are getting that same current dividend, their effective yield is higher. And over time, it can grow very high indeed.
The Motley Fool September 19, 2008 Todd Wenning	How to Weather Market Panics Wall Street is in panic mode. You don't need to be.
The Motley Fool November 18, 2010 Selena Maranjian	Make Up for Lost Time With These Stocks It's not too late to build a better portfolio. Let's examine several different categories of stocks, and the advantages they can bring to your holdings.
The Motley Fool August 11, 2006 Nathan Parmelee	The Best Dividend Payers of the Past Decade It's not a complete surprise that the best returns among dividend payers would come from smaller companies: Corporate Office Properties Trust... BP Prudhoe Bay Royalty Trust... MDC Holdings... etc.
The Motley Fool August 8, 2006 Selena Maranjian	4 Blue-Chip Bargains Have you noticed? Some big and beautiful companies are selling at attractive prices. Wal-Mart... Home Depot... PepsiCo... Johnson & Johnson...